Cargando…
Ultraexpensive gene therapies, industry interests and the right to health: the case of onasemnogene abeparvovec in Brazil
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915307/ https://www.ncbi.nlm.nih.gov/pubmed/35277426 http://dx.doi.org/10.1136/bmjgh-2022-008637 |
| _version_ | 1784667989944041472 |
|---|---|
| author | Ivama-Brummell, Adriana Mitsue Wagner, Anita K Pepe, Vera Lúcia Edais Naci, Huseyin |
| author_facet | Ivama-Brummell, Adriana Mitsue Wagner, Anita K Pepe, Vera Lúcia Edais Naci, Huseyin |
| author_sort | Ivama-Brummell, Adriana Mitsue |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8915307 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89153072022-03-25 Ultraexpensive gene therapies, industry interests and the right to health: the case of onasemnogene abeparvovec in Brazil Ivama-Brummell, Adriana Mitsue Wagner, Anita K Pepe, Vera Lúcia Edais Naci, Huseyin BMJ Glob Health Commentary BMJ Publishing Group 2022-03-11 /pmc/articles/PMC8915307/ /pubmed/35277426 http://dx.doi.org/10.1136/bmjgh-2022-008637 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Commentary Ivama-Brummell, Adriana Mitsue Wagner, Anita K Pepe, Vera Lúcia Edais Naci, Huseyin Ultraexpensive gene therapies, industry interests and the right to health: the case of onasemnogene abeparvovec in Brazil |
| title | Ultraexpensive gene therapies, industry interests and the right to health: the case of onasemnogene abeparvovec in Brazil |
| title_full | Ultraexpensive gene therapies, industry interests and the right to health: the case of onasemnogene abeparvovec in Brazil |
| title_fullStr | Ultraexpensive gene therapies, industry interests and the right to health: the case of onasemnogene abeparvovec in Brazil |
| title_full_unstemmed | Ultraexpensive gene therapies, industry interests and the right to health: the case of onasemnogene abeparvovec in Brazil |
| title_short | Ultraexpensive gene therapies, industry interests and the right to health: the case of onasemnogene abeparvovec in Brazil |
| title_sort | ultraexpensive gene therapies, industry interests and the right to health: the case of onasemnogene abeparvovec in brazil |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915307/ https://www.ncbi.nlm.nih.gov/pubmed/35277426 http://dx.doi.org/10.1136/bmjgh-2022-008637 |
| work_keys_str_mv | AT ivamabrummelladrianamitsue ultraexpensivegenetherapiesindustryinterestsandtherighttohealththecaseofonasemnogeneabeparvovecinbrazil AT wagneranitak ultraexpensivegenetherapiesindustryinterestsandtherighttohealththecaseofonasemnogeneabeparvovecinbrazil AT pepeveraluciaedais ultraexpensivegenetherapiesindustryinterestsandtherighttohealththecaseofonasemnogeneabeparvovecinbrazil AT nacihuseyin ultraexpensivegenetherapiesindustryinterestsandtherighttohealththecaseofonasemnogeneabeparvovecinbrazil |